Also available in Persian — نسخه فارسی ✈️ Telegram EN فا
❓ Unknown

Single Dose of Liver Nanovesicles Shows Promise in Treating Alcohol-Related Liver Disease

Just now November 4, 2026 1 min read 📰 Medical Xpress
📋 Key Takeaway

Research published in The American Journal of Pathology indicates that liver matrix-bound nanovesicles from healthy porcine tissue may reduce liver damage in alcohol-related liver disease. This study highlights a potential new therapeutic approach for liver disease, which is relevant for Iran where alcohol-related health issues are significant. The findings could influence future healthcare strategies in the country.

Alcohol-related liver disease (ALD) is characterized by hepatocellular injury, oxidative stress, inflammation and extracellular matrix remodeling, yet effective therapies remain limited. New research in The American Journal of Pathology, found that a single dose of liver matrix-bound nanovesicles (MBVs) derived from healthy porcine tissue reduced liver injury, fat accumulation and oxidative stress in alcohol-fed mice, pointing to a possible new therapeutic strategy for ALD.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 100%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →